Federal spending for illness caused by the human immunodeficiency virus.
Federal spending for illness caused by the human immunodeficiency virus.
复制标题
用于治疗人类免疫缺陷病毒引起的疾病的联邦支出。
DOI：
10.1056/nejm198906153202406
复制
发表时间：
1989
期刊：
影响因子：
--
通讯作者：
Rhonda M. Stolec
中科院分区：
文献类型：
--
作者：
W. Winkenwerder;Austin R. Kessler;Rhonda M. Stolec
联邦政府是否投入了足够的资源来抗击人类免疫缺陷病毒（HIV）感染的流行，这些资源的使用是否适当？一些观察家认为，这些金额还不够，但到目前为止，还没有对联邦抗击这一流行病的活动和支出进行全面核算。我们报告了 1982 年至 1989 年从联邦机构收集的支出数据。在此期间，联邦政府总共花费了 55 亿美元用于治疗艾滋病毒相关疾病，其中近 60% 用于美国公共卫生服务。 1989 年，联邦用于艾滋病毒相关疾病的支出将达到 22 亿美元，占全国（公共和私人）艾滋病毒支出估计数的三分之一以上，是国家支出的三倍。 1992年，联邦应对流行病的支出估计将达到43亿美元。尽管数额很大，但这仅占 1992 年联邦医疗卫生经费总额的 1.8%。同样，1992 年，国家（公共和私人）用于艾滋病毒相关疾病的支出将占美国所有健康相关费用的约 1.6%。联邦用于艾滋病毒研究和预防的支出与用于其他主要疾病的资金类似，包括癌症和心脏病等目前对死亡率影响更大的疾病。
Is the federal government devoting sufficient resources to fighting the epidemic of human immunodeficiency virus (HIV) infection, and are these resources being spent appropriately? Some observers contend that the amounts have been inadequate, but until now there has been no overall accounting of federal activities and spending to combat the epidemic. We report expenditure data collected from federal agencies for the years 1982 to 1989. In all, $5.5 billion will have been spent on HIV-related illness during this period by the federal government, nearly 60 percent of it by the U.S. Public Health Service. Federal spending on HIV-related illness in 1989 will reach $2.2 billion, representing over one third of all estimated national (public and private) HIV expenditures, and tripling state expenditures. In 1992, federal spending on the epidemic will reach an estimated $4.3 billion. Although sizable, this will be just 1.8 percent of all 1992 federal health dollars. Similarly, in 1992, national (public and private) spending on HIV-related illness will consume roughly 1.6 percent of all health-related costs in the United States. Federal spending for HIV research and prevention is similar to funding for other major diseases, including some conditions, such as cancer and heart disease, that now have a greater impact on mortality.